ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Acne,Acnes,Skin appendage conditions,Skin,N
2,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
2,3,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
3,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
3,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
5,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
6,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
7,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
8,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
8,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
8,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
